Gates Foundation allots $120 million for poor nations to get COVID-19 drug Reuters Oct 21, 2021 The money will support efforts to develop and make generic versions of what could become the first oral antiviral medication for…
Natco commences phase-III clinical trial of Molnupiravir for COVID-19 treatment EP News Bureau May 21, 2021 First patient was dosed at Yashoda Hospitals, Hyderabad
Optimus Pharma gets DCGI nod for Phase III trials of Molnupiravir for COVID-19 treatment EP News Bureau May 19, 2021 As per the clinical trial protocol approved, 2500 subjects with mild to moderate COVID-19 will be randomised in the study in a 1:1…
NATCO applies to CDSCO for EUA of Molnupiravir capsules to treat COVID-19 EP News Bureau Apr 26, 2021 Pre-clinical data have shown that Molnupiravir has broad anti-influenza activity, including highly potent inhibition of SARS-CoV-2…